Medpace Holdings Inc. (MEDP), which reported strong financial results for the first quarter ended March 31, 2024, expects revenue for this year to grow in the range of 14.0% to 16.7%.
The company is a global full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
Q1 Scorecard
On a GAAP basis, net income for the first quarter of 2024 surged to $102.6 million or $3.20 per share from $72.9 million or $2.27 per share in the first quarter of 2023.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.